Tandem Diabetes (TNDM) Tops Q4 EPS by 11c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results
February 24, 2016 4:05 PM ESTSAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4 Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2015.
In comparing the fourth quarter of 2015 to the same period of 2014:
Sales grew 63 percent to $29.1 million from $17.9 million Pump shipments grew 59 percent to 6,234 pumps from 3,929 pumps Operating margin improved to negative 39 percent from negative 98 percentIn comparing the year ended December 31, 2015 to the same... More
